Home » EpiCept to End Drug-Discovery Efforts, Cut 65 Percent of Jobs
EpiCept to End Drug-Discovery Efforts, Cut 65 Percent of Jobs
EpiCept Corp., the Tarrytown, N.Y., drugmaker, said that it is ending its drug-discovery activity, cutting 65% of its workforce, and focusing on registering Ceplene for marketing in the U.S. and Canada and on clinical-development programs.
MarketWatch
MarketWatch
Upcoming Events
-
07May
-
14May
-
30May